Amoeba SA (ALMIB)

Currency in EUR
0.8730
-0.0170(-1.91%)
Real-time Data·
ALMIB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.85200.8880
52 wk Range
0.78001.4438
Key Statistics
Prev. Close
0.89
Open
0.888
Day's Range
0.852-0.888
52 wk Range
0.78-1.4438
Volume
103.6K
Average Volume (3m)
350.21K
1-Year Change
-31.0971%
Book Value / Share
-0.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALMIB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.2500
Upside
+43.18%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1.2500
(+43.18% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
23-02-2026
EPS / Forecast
-0.07 / --
Revenue / Forecast
-329.19K / --
EPS Revisions
Last 90 days

ALMIB Income Statement

Compare ALMIB to Peers and Sector

Metrics to compare
ALMIB
Peers
Sector
Relationship
P/E Ratio
−7.3x5.5x2.7x
PEG Ratio
1.160.060.00
Price/Book
−11.4x1.0x1.6x
Price / LTM Sales
87.6x0.6x1.4x
Upside (Analyst Target)
41.6%18.4%26.7%
Fair Value Upside
Unlock9.3%−1.4%Unlock

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. Amoéba S.A. was incorporated in 2010 and is headquartered in Chassieu, France.

Industry
Chemicals
Employees
23
Market
France

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
408.04K0.59%346.83K
Other Institutional Investors
15.26M22.15%12.97M
Public Companies & Retail Investors
53.22M77.26%45.24M
Total
68.89M100.00%58.55M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Nice & Green SA22.15%1,52,55,54112,967
MW Gestion SA0.37%2,53,770216

FAQ

What Is the Amoeba SA (ALMIB) Share Price Today?

The Amoeba SA share price today is 0.8730.

What is the current Amoeba SA (ALMIB) share price and day range?

As of 30-04-2026, the Amoeba SA share price is 0.8730, with a previous close of 0.8900. The share price has ranged from 0.8520 to 0.8880 today, while the 52-week range spans from 0.7800 to 1.4438.

What Is the Amoeba SA Market Cap?

As of today, Amoeba SA market cap is 60.4100M.

What Is the Amoeba SA (ALMIB) Share Price Target?

The average 12-month share price target for Amoeba SA is 1.2500, with a high estimate of 1.4 and a low estimate of 1.1. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +43.18% Upside potential.

What Is Amoeba SA's Earnings Per Share (TTM)?

The Amoeba SA EPS (TTM) is -0.1412.

From a Technical Analysis Perspective, Is ALMIB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

What Stock Exchange Does Amoeba SA Trade On?

Amoeba SA is listed and trades on the Paris Stock Exchange.

What Is the Stock Symbol for Amoeba SA?

The stock symbol for Amoeba SA is "ALMIB."

How Many Times Has Amoeba SA Stock Split?

Amoeba SA has split 0 times.

How Many Employees Does Amoeba SA Have?

Amoeba SA has 23 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.